Skip to content

Clinical study of smear positive pulmonary TB chemotherapy combined with local low frequency ultrasound therapy conductance

Clinical study of smear positive pulmonary TB chemotherapy combined with local low frequency ultrasound therapy conductance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16009138
Enrollment
Unknown
Registered
2016-09-01
Start date
2016-09-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smear positive pulmonary tuberculosis

Interventions

Group Therapy :Anti-TB chemotherapy combined with local low frequency ultrasound therapy conductance
Group:Simple anti-TB drugs

Sponsors

Affiliated Hospital of Zunyi Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for active tuberculosis and invasive diagnosis, cheese bronchial pneumonia or tuberculosis sputum-positive; 2. Patients aged between 14 to 65 years old; 3. Initial treatment or retreatment of not more than 2 times persons; 4. By chest X-ray or chest CT pulmonary infiltrates tuberculosis lesions; 5. Unilateral lesion of not more than two lobes; 6. Have voluntarily signed an informed consent.

Exclusion criteria

Exclusion criteria: 1. The diagnosis of chronic fibrous hollow, tuberculoma person; 2. fungal infection; 3. The artificial implant stents, artificial valves and pacemakers; 4. pregnant women with severe heart, lung, liver, kidney dysfunction and AIDS, diabetes; 5. The existence of significant hearing impaired.

Design outcomes

Primary

MeasureTime frame
Sputum negative conversion rate;

Secondary

MeasureTime frame
General clinical improvement, including body temperature, spirit, appetite, sleep, physical;

Countries

China

Contacts

Public ContactLing Chen

Affiliated Hospital of Zunyi Medical College

lingjuncd@163.com+86 15885623368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026